Phase 2 Oesophageal Cancer Trial, Recruiting NCT02297217 Sponsor: AHS Cancer Control Alberta Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Phase 2 Oesophageal Cancer Trial, Recruiting

NCT02297217
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with esophageal cancer (confirmed by a biopsy).
  • Your cancer cannot be treated with the goal of a full cure, due to how advanced it is, whether it has spread to other parts of the body, or because of other serious health conditions you have.
  • You are having trouble swallowing and can only manage eating some solid foods.
  • You are generally well enough to carry out some daily activities (confirm with trial site regarding the specific fitness level required).
  • You are able to start treatment within 14 days of signing the consent form.
  • You are at least 18 years old.
  • Your blood counts are at an acceptable level, including red blood cells, platelets, and white blood cells (confirm specific values with trial site).
  • Your liver and kidneys are working well enough to receive chemotherapy (confirm specific values with trial site).
  • If you are able to have children, you are using adequate contraception.
  • You are willing and able to give written informed consent to take part.

Who may not be able to join:

  • You have previously had radiotherapy (radiation treatment) to your chest area.
  • You currently have another active cancer at the same time.
  • You are pregnant or breastfeeding, or you are unwilling or unable to use two forms of birth control from the time of signing the consent form until 120 days after finishing or leaving the study.
  • You have a health condition that makes any part of the treatment unsafe for you, including any reason you absolutely cannot have radiation therapy, or if you have a connective tissue disease (confirm with trial site).
  • You have an abnormal opening between your windpipe and food pipe (tracheo-esophageal fistula).
  • You already have a stent (a small tube) placed inside your food pipe (esophagus).
  • You have previously had chemotherapy for esophageal cancer.
  • You are unable to complete questionnaires written in English without the help of an interpreter.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Marc Kerba, MD, 5872316617

Phone: 5872315492

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
AHS Cancer Control Alberta
Registry
ClinicalTrials.gov
Start date
21 November 2019
Est. completion
30 April 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Proportion of patients who achieve relief of dysphagia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov